Target intelligence / Profile preview

RIDA pseudogene 1 (RIDAP1)

Target
RIDAP1
Molecular classification
Other (Pseudogene)
01

Overview

RIDA pseudogene 1 (RIDAP1) is a pseudogene, meaning it is a DNA sequence that resembles a protein-coding gene but is typically non-functional due to mutations or lack of regulatory elements required for expression. It is not known to encode an active protein, nor does it serve a recognized biological function as a therapeutic target, receptor, enzyme, transporter, or other typical drug target class[2][6][7]. The functional RIDA gene encodes an enzyme involved in mRNA catabolic processes and the hydrolytic deamination of enamine/imine intermediates[1][3][5]; however, RIDAP1 does not have such activity. Additional context: - Pseudogenes like RIDAP1 may occasionally have roles in gene regulation in some contexts (such as production of non-coding RNAs or acting as microRNA sponges), but no such function is reported or established for RIDAP1 specifically[2][4]. - Since it is not a functional protein, there are no known disease roles, biomarker uses, drug interactions, or therapeutic mechanisms for RIDAP1[2][6]. - This entry is considered incorrect as a therapeutic target because it is a pseudogene, not a protein-coding gene or druggable target[6][7]. Summary: RIDAP1 (RIDA pseudogene 1) is a pseudogene and does not correspond to an active molecular target for therapeutics, diagnostics, or biomarker applications. There is no evidence of function, disease involvement, or representational value as a canonical drug target.

Other names
RIDAP1

Beyond the preview

Go deeper on RIDA pseudogene 1 (RIDAP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RIDA pseudogene 1 (RIDAP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call